New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 16, 2012
07:24 EDTNUVACorrection: NuVasive upgraded to Overweight from Equal Weight at First Analysis
First Analysis upgraded NuVasive based on valuation and its attractive product portfolio. Price target is $17.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
16:10 EDTNUVANuVasive sees Ellipse acquisition accretive to 2016 EPS by 1c
Sees acquisition accelerating NuVasive revenue growth to high single-digits in 2016.
16:09 EDTNUVANuVasive to selectively explore M&A opportunities
"Very selectively, we also intend to explore compelling inorganic opportunities that add value, such as today's completion of the acquisition of Ellipse Technologies, and reinforce our focus on transformative spine solutions," the company said.
16:08 EDTNUVANuVasive sees FY16 adjusted EPS $1.48, consensus $1.49
Sees FY16 revenue $923M, consensus $881.1M.
16:07 EDTNUVANuVasive reports Q4 adjusted EPS 35c, consensus 31c
Reports Q4 revenue $215.3M, consensus $215.27M.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use